Search
Descriptor in English: Melphalan
Descriptor in Spanish: Melfalán
Descriptor in Portuguese: Melfalan
Descriptor in French: Melphalan
Entry term(s): 4-(Bis(2-chloroethyl)amino)phenylalanine
Alkeran
L-PAM
Medphalan
Merphalan
Mustard, Phenylalanine
Phenylalanine Mustard
Sarcolysine
Sarkolysin
Tree number(s): D02.455.526.728.650.594
D12.125.072.050.685.500
Scope note: An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
DeCS UI: 8727
Descriptor UI: D008558
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2013/07/08
Melphalan - Preferred
Concept UI M0013330
Scope note An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen.
Preferred term Melphalan
Entry term(s) 4-(Bis(2-chloroethyl)amino)phenylalanine
L-PAM
Mustard, Phenylalanine
Phenylalanine Mustard
Medphalan - Related but not broader or narrower
Concept UI M0013329
Preferred term Medphalan
Sarkolysin - Related but not broader or narrower
Concept UI M0013331
Preferred term Sarkolysin
Entry term(s) Merphalan
Sarcolysine
Alkeran - Narrower
Concept UI M0013332
Preferred term Alkeran



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey